Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-11-12
2010-06-22
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S210170, C514S210180, C514S210190, C514S210200, C514S210210, C548S950000, C548S152000, C548S202000, C548S217000, C548S364100, C548S518000, C544S060000, C544S111000, C544S242000, C544S359000, C546S139000, C546S150000, C546S176000, C546S268100
Reexamination Certificate
active
07741316
ABSTRACT:
A method of treating or preventing Alzheimer's disease, Parkinson's Disease and/or schizophrenia, this method comprising administering to a patient in need of such treatment a compound of formula:in which R, R3and R4are as defined in the specification.
REFERENCES:
patent: 4260606 (1981-04-01), Cale, Jr. et al.
patent: 5073646 (1991-12-01), Pinol et al.
patent: 6022868 (2000-02-01), Olesen et al.
patent: 6379666 (2002-04-01), Tobinick
patent: 2002/0081584 (2002-06-01), Blumenfeld et al.
DiMarzo et al. 2000, Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J., vol. 14, pp. 1432-1438.
Poncelet et al. 1999, Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils. Psychopharmacology, vol. 144, pp. 144-150.
Arnone et al. 1997, Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology, vol. 132, pp. 104-106.
Barth F et al, The development of cannabinoid antagonists, Curr. Med. Chem., vol. 6(8), Aug. 1999, pp. 745-755.
Brotchie JM, CB1 cannabinoid receptor signalling in Parkinson's disease, Curr. Opin. Pharmacol., vol. 3(1), Feb. 2003, pp. 54-61.
Ruiu S et al, Synthesis and Characterization of NESS 0327: A Novel Putative Antagonist of the CB1 Cannabinoid Receptor, J. Pharmacol. Exp. ther., vol. 306(1), Jul. 2003, pp. 363-370.
Tzavara ET et al, The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortax: implications for therapeutic actions, J. Pharmacol., vol. 138(4), Feb. 2003, pp. 544-553.
W. E. Bachmann;Journal of the American Chemical Society; “The Relative Stability of Penta-Arylethanes I. The Preparation of Penta-Arylethanes”; May 1933; vol. 56; pp. 2135-2139.
A. L. Plasz et al.;Journal of the Chemical Society, Chemical Communications; “Photolytic Reduction of Phenyl Quinolin-3-yl Ketone to 3-Benzylquinoline”; 1972; pp. 527.
M. Hudlicky;ACS Monograph Series #186; “Oxidations in Organic Chemistry”; 1990; pp. 252-263.
G.A. Brine et al.;Journal of Heterocyclic Chemistry; “Carbon-13 Nuclear Magnetic Resonance Spectra of Fentanyl Analogs”; May-Jun. 1989; vol. 26; pp. 677-686.
D. Nagarathnam;Synthesis; “A Simple Synthesis of 2-Substituted Indoles”; Aug. 1992; pp. 743-745.
A. R. Katritzky et al.;Journal of Heterocyclic Chemistry; “Novel Syntheses of 1,3,3-Trinitroazetidine”; Mar.-Apr. 1994; vol. 31; pp. 271-275.
P. R. Dave;Journal of Organic Chemistry; “Acylative Dealkylation ofN-tert-Butyl-3-substituted Azetidines: Facile Access to [1.1.0] Azabicyclobutane, 3-Hydroxyazetidinium Hydrochloride, and 3-Azetidinones”; 1996; vol. 61; pp. 5453-5455.
M. Grisar et al.;Journal of Medicinal Chemistry; “Benzhydryl and Fluorenyl Lactamimides with Hypoglycemic, Diuretic, Blood Platelet Aggregation Inhibitory, and Antiinflammatory Activities”; 1973; vol. 16, No. 8; pp. 885-893.
N. G. Kundu et al.;Journal of the Chemical Society, Perkin Transactions 1; “Palladium-catalysed heteroannulation with acetylenic compounds: synthesis of benzofurnas”; 1997; pp. 2815-2820.
M. Moreno-Mañas et al.;European Journal of Medicinal Chemistry; “New imidazole anti-fungal agents derived from benzo[b]thiophene. Part II”; 1988; vol. 23; pp. 477-482.
Skinner et al.;Journal of Medicinal Chemistry; “Antiviral Agents. 1. Benzothiazol and Benzoxazole Analogs of 2-(α-Hydroxybenzyl)benzimidazole”; 1971; vol. 14, No. 6; pp. 546-549.
N. K. Harn;Tetrahedron Letters; “Acylation of Oxazoles by the Copper-Mediated Reaction of Oxazol-2-ylzinc Chloride Derivatives”; 1955; vol. 36, No. 52; pp. 9453-9456.
A. Medici et al.;Tetrahedron Letters; “Reactions of 2-Trimethylsilylthiazole with Acyl Chlorides and Aldehydes Synthesis of New Thiazol-2-YL Derivatives”; 1983; vol. 24, No. 28; pp. 2901-2904.
R. D. Riecke et al.;Journal of Organic Chemistry; “Direct Preparation of 3-Thienyl Organometallic Reagents: 3-Thienylzinc and 3-Thienylmagnesium Iodides and 3-Thienylmanganese Bromides and Their Coupling Reactions”; 1997; vol. 62, No. 20; pp. 6921-6927.
J. Knabe et al.;Archives of Pharmacology; “Synthese von 1-Acylisochinolinen über Reissert-Verbindungen”; 1973; vol. 306(9), pp. 648-658.
R. Consonni et al.;Journal of the Chemical Society—Perkin Transactions 1; “Diels-Alder reactions ofN-sulfonyl substituted aza-ortho-xylylenes generated from the corresponding 1,4-dihydro-2H-3,1-benzoxazin-2-one derivatives”; 1996; pp. 1809-1814.
L. Brandsma et al.;Synthetic Communications; “A Large-Scale Procedure for the Preparation of 3-Bromothiophene From 2-Bromothiophene and Sodamide in Liquid Ammonia”; 1990, vol. 20(11); pp. 1697-1700.
M. Lemaire et al.;Synthetic Communications; “A Convenient Synthesis of 3-Fluorothiophene”; 1994; vol. 24(11); pp. 95-101.
H. Goda et al.;Synthesis; “Facile Synthesis of 5-Substituted 2-Acetylthiophenes”; 1992; vol. 9; pp. 849-851.
P. Baeuerle et al.;Journal of the Chemical Society-Perken Transactions 2; “Synthesis and Structural Characterization of Alkyl Oligothiophenes—The First Isomerically Pure Dialkylsexithiophene”; 1993; pp. 489-494.
P. Bouyssou et al.;Journal of Heterocyclic Chemistry; “Synthesis of 7- and 5,7-Substituted-6-fluoro-2-methyl-1,2,3,4-tetrahydroquinolines: Convenient Precursors of Quinolone Antibacterial Agents”; 1992; vol. 29(4); pp. 895-898.
N. Suzuki et al.;Journal of the Chemical Society, Chemical Communications; “Synthetic Reactions in Polyethylene Glycol. Diazotization and Sandmeyer Reactions of Anilines in Polyethylene Glycol-Methylene Dichloride”; 1984; pp. 1523-1524.
S. Marburg et al.;Journal of Heterocyclic Chemistry; “A Short Efficient Synthesis of 4-Amino-2,3-dihydrobenzofuran”; 1980; vol. 17; pp. 1333-1335.
V. Percec et al.;Journal of Organic Chemistry; “Aryl Mesylates in Metal Catalyzed Homo- and Cross-Coupling Reactions. 4. Scope and Limitations of Aryl Mesylates in Nickel Catalyzed Cross-Coupling Reactions”; 1995; vol. 60(21); pp. 6895-6903.
J. F. Hansen et al.;Journal of Heterocyclic Chemistry; “Synthetic Studies Leading to DE-Ring Analogs of Camptothecin (1)”; 1973; vol. 10; pp. 711-714.
L. E. Hollister;Pharmacological Reviews; “Health Aspects of Cannabis”; 1986; vol. 38; pp. 1-20.
S. Renu;Progress in Drug Research; “Chemistry and Pharmacology of Cannabis”; 1991; vol. 36; pp. 71-115.
S. Consroe;Marijuana/Cannabinoids: Neurobiology and Neurophysiology(Eds. Murphy, L.; Barthe. A.); “Potential Role of Cannabinoids for Therapy of Neurological Disorders”; 1992; pp. 459-524.
J. E. Kuster; J. I. Stevenson et al.;Journal of Pharmacology and Experimental Therapeutics; “Aminoalkylindole Binding in Rat Cerebellum: Selective Displacement by Natural and Synthetic Cannabinoids”; 1993; vol. 264; pp. 1352-1363.
T. Hayashi et al;Journal of the American Chemicl Society; “Dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium-(II): An Effective Catalyst for Cross-Coupling of Secondary and Primary Alkyl Grignard and Alkylzinc Reagents with Organic Halides”; 1984; vol. 106; pp. 158-163.
J. Wityak et al.;Bioorganic and Medicinal Chemistry Letters; “Synthesis and Antiplatelet Activity of DMP 757 Analogs”; 1995; vol. 5(18); pp. 2097-2100.
M. Desai; L. Stramiello;Tetrahedron Letters; “Polymer Bound EDC (P-EDC): A Convenient Reagent for Formation of an Amide Bond”; 1993; vol. 34(48); pp. 7685-7688.
G. Pandey; T. D. Bagul et al.;Journal of Organic Chemistry; “[3+2] Cycloaddition of Nonstabilized Azomethine Ylides. 7. Stereoselective Synthesis of Epibatidine and Analogues”; 1998; vol. 63; pp. 760-
Achard Daniel
Bouchard Herve
Bouquerel Jean
Filoche Bruno
Grisoni Serge
Aventis Pharma S.A.
Gupta Balaram
McMillian Kara R
Padmanabhan Sreeni
LandOfFree
Pharmacological uses of azetidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacological uses of azetidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacological uses of azetidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4152049